Cancer
CD20 188-196 (HLA-A*02:01) SLFLGILSV
Product number: EP07888_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide (SLFLGILSV) for stimulation of human CD20 (188-196)-specific CD8+ T-cells.
TechData
| Sequence: | SLFLGILSV |
| Gene: | MS4A1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | B-lymphocyte antigen CD20 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer, Neuroscience |
| Purity: | 95% HPLC-MS |